The researchers analyzed data from 9,544 mpox cases among men between the ages of 18 and 49 that were reported during July 31 through Oct. 1 from 43 U.S. jurisdictions. There was not a significant variation of efficacy between whether the vaccine was delivered intradermally — when a fifth of a dose is administered in between layers of skin — or subcutaneously, but to “optimize strength of protection,” eligible people should receive two doses, the researchers wrote.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
